Oxfam logo
The Future is Equal

Oxfam logo in green

people's vaccine

Oxfam reacts to reports of a compromise on vaccines TRIPS waiver

In response to reports of a potential compromise agreed by the EU, South Africa, India and the US for a waiver of intellectual property rules for COVID vaccines, Max Lawson, Head of Inequality Policy for Oxfam and co-chair of the People’s Vaccine Alliance, said:

“After almost 18 months of stalling and millions of deaths, the EU has climbed down and finally admitted that intellectual property rules and pharmaceutical monopolies are a barrier to vaccinating the world. This is a tribute to millions of campaigners across the world who have demanded a Peoples Vaccine, but this leaked proposal is not the comprehensive TRIPS waiver demanded by over 100 governments. Unless it is significantly improved it will not do enough to bring an end to vaccine apartheid and ensure access for all.

“As it stands, this proposal seems to do little to address patents beyond the existing flexibilities in the TRIPS agreement. It ignores other intellectual property barriers like trade secrets that stand in the way of vaccine manufacturers. And by focusing only on vaccines and kicking the issue of COVID-19 treatments into the long grass, it will leave lifesaving treatments out of reach for millions.

“In a crisis, half measures are not acceptable. Every barrier to accessing these crucial vaccines and treatments must be cleared away. We urge member states to return to the negotiating table and come back with a comprehensive waiver that will work to cut short this pandemic and guarantee everyone is protected.”

COVID-19 death toll four times higher in lower-income countries than rich ones

3 million people died since the Omicron variant emerged, shattering perceptions that the pandemic is over

The COVID-19 death toll has been four times higher in lower-income countries than in rich ones, according to a new report published today by Oxfam on behalf of the People’s Vaccine Alliance as the world marks two years since the World Health Organisation declared the pandemic.

While the pandemic has been devastating for rich countries like Aotearoa New Zealand the world’s poorest countries have been hardest hit, with women and children bearing a disproportionate burden. Lack of testing and reporting means that very large numbers of deaths due to COVID-19 go unreported, especially in the poorest countries. Modelling using measures of excess deaths estimates that 19.6 million people have died because of COVID-19, over three times the official death toll. Based on this analysis, Oxfam calculated that for every death in a high-income country, an estimated four other people have died in a low or lower-middle income country. On a per capita basis, deaths in low and lower middle-income countries are 31% higher than high income countries.

Oxfam also calculated that three million COVID-19 deaths have occurred in the three months since the Omicron variant emerged. The figure shatters perceptions that Omicron’s milder illness means the pandemic is coming to an end, as the more contagious variant tears through unvaccinated populations. By some estimates, over half of humanity is set to have been infected with COVID-19 by the end of March 2022. While most cases will be mild, the sheer number of cases means that numbers of deaths remain high. 

The report also outlines that:

  • Every minute, four children around the world have lost a parent or caregiver to COVID. In India alone, more than two million children lost a caregiver.
  • Women have been 1.4 times more likely to drop out of the labour force than men because of the pandemic.
  • 73 percent of people in high income countries are fully vaccinated while just six percent of people in low-income countries are.

However, not everyone has lost out due to the pandemic, with a new billionaire created every 26 hours. Of those new billionaires, 40 are COVID-19 billionaires, having made their billions profiting from vaccines, treatments, tests, and personal protective equipment (PPE). During the pandemic, the world’s 10 richest men have seen their fortunes double, rising at a rate of $1.3 billion a day, or $15,000 dollars a second.

Anna Marriott, Oxfam’s Health Policy Manager, said:

“After two years, we all want this pandemic to be over, but politicians in rich countries are exploiting that fatigue to ignore the devastating impact of COVID-19 that continues to this day.

“While incredibly effective vaccines provided hope, rich countries derailed the global vaccine rollout with nationalism, greed, and self-interest. Suggestions that we are entering a ‘post-COVID era’ ignore the continuing deaths in primarily lower-income countries that could be prevented by vaccines.”

Oxfam is part of the People’s Vaccine Alliance, a global coalition of nearly 100 organisations, campaigning for vaccine equity through support for a waiver of intellectual property rules on COVID-19 vaccines and treatments, and by making pharmaceutical companies share their science and knowhow with qualified producers in developing countries, so they are able to make their own doses.

Maaza Seyoum, Global South Convenor for the People’s Vaccine Alliance, said:

“Rich countries and corporations have tied up the global response to COVID-19 for their own benefit, leaving the global south to bear the brunt of this pandemic.

“As billions of people are still unable to access vaccines, some have the audacity to claim that the pandemic is over. That is an utter fallacy. Third and fourth doses in rich countries alone cannot erase the ever-rising death toll in lower-income countries.

“The charity approach to global vaccination has failed. Global south countries can and must manufacture vaccines and treatments for themselves – and they must maintain control of their own supplies. Rich countries must waive intellectual property rules on COVID-19 technologies and force big pharma to share the recipes.”

The report, Pandemic of Greed, warns that dangerous myths have fuelled the pandemic and excused a lack of bold and innovative policy action.

Gregg Gonsalves, Associate Professor of Epidemiology at Yale University, said:

“While Omicron tends to lead to a milder illness in many, the variant’s higher transmissibility means it can cut a deadly swath through countries, particularly among the unvaccinated. We may all be done with the coronavirus, but the coronavirus is not done with all of us.

“There must be a better way out of the suffering of the past two years, a way where everyone had access to vaccines, and no one was disposable. Public health decisions must be based on comprehensive evidence, not political agendas.

“The ‘post-COVID’ narrative emerging from rich countries will only worsen the complacency that has plagued the global fight against COVID-19. The global south understandably wants to take things into their own hands – and rich countries should let them.” 

Notes:

See the full report here.

EU leaders’ refuse to consider AU calls for a waiver on COVID-19 vaccines

Today, African Union and European Union leaders discussed the global vaccine rollout and calls to support the current proposal at the World Trade Organisation (WTO), tabled by India and South Africa and backed by 100 countries, to temporarily suspend intellectual property rules for Covid-19 vaccines, tests, and treatments.

In response, Peter Kamalingin, Oxfam Pan Africa Programme Director said:

“EU leaders continue to make a song and dance about the importance of their relationship with the African continent. Yet they once again put the interests of their profit-hungry pharmaceutical corporations first. The point-blank refusal to even consider the waiver at this summit is shameful and an insult to the millions of people in poorer countries who have needlessly lost loved ones because of vaccine inequity. While Europeans are getting boosters, nearly 90 per cent of Africans are yet to have their initial two doses.

“What Africans need is equal and fair access to vaccines. The ‘charity model’ has failed. Europe has already thrown away more vaccines than they donated to African countries this year. It is time for African leaders, governments and people around the world to seriously call into question Europe’s commitment to their so-called ‘partnership of equals’.

“Instead of siding with Big Pharma who are making billions out of vaccines, the EU and European countries must stop kicking the can down the road and support the full waiver and insist the vaccine technology is shared. This is the only way to ensure we can supply and distribute vaccines, tests and treatments – to everyone, everywhere and bring an end to this pandemic.”

 

Notes to editors

BioNTech to ship mobile vaccine factory containers to Africa

Responding to the announcement that BioNTech plans to ship mobile vaccine factory containers to Africa, which could start producing vaccines in the second half of 2023, Oxfam’s Health Policy Manager, Anna Marriott, said:

“Efforts to boost vaccine manufacturing in Africa are welcome but this is a long-term project and should not distract from the failure of rich country governments and companies, including Germany and BioNTech, to tackle today’s shameful vaccine inequality responsible for millions of needless deaths in poorer countries from this pandemic.

“It is unacceptable that BioNTech, along with other pharma giants, is ignoring the World health Organisation’s mRNA Hub in Africa which is ready to produce vaccines and expand manufacturing in favour of a BioNTech controlled vaccine container module that won’t be producing vaccines for well over a year.

“To date, Germany has exported just one per cent of its vaccines to the African continent. If Germany is serious about tackling vaccine inequality it must reverse its refusal to support the waiving of intellectual property rules for these life-saving pandemic tools and insist BioNTech transfer their technology now to the WHO so that existing manufacturers across Africa, Latin America and Asia can make them.

“Serious questions must also be raised about BioNTech’s objectives with this initiative. Last week it was revealed that a consultancy on BioNTech’s payroll, the kENUP Foundation, is trying to undermine the work of a World Health Organisation and South African-led project to make mRNA COVID vaccines as a global public good and free of big pharma’s control.”

Countries to count donations of unwanted vaccine doses as part of their foreign aid commitment

In response to the statement issued today by the Organisation for Economic Co-operation and Development’s (OECD) Development Assistance Committee, which says that countries will be able to count donations of unwanted vaccine doses as part of their foreign aid commitment, for a guideline cost of $6.72 a dose, Oxfam’s Health Policy Manager, Anna Marriott, said:

“This guidance is a double insult to the world’s poorest countries. First, rich countries bought many more doses than they could use at a time of limited supply, preventing millions of people in developing countries from getting life-saving vaccines. Now they are free to charge any donations of unwanted doses to their aid budgets, to the detriment of other essential aid spending.

“Rich countries should donate any excess doses immediately to developing countries, but this should not be  at the expense of aid countries desperately need to help save lives. It is not only immoral, but there’s a high chance of failure if the donations replace aid that would have supported health systems and other non-vaccine related costs that are critical for their delivery, especially at a time when COVAX has run out of funds.

“Due to the lack of safeguards in this guidance, rich countries could count donated vaccines as aid that can never reach arms, because they are donated too close to expiry or without essential equipment such as syringes. Between them G7 countries currently have over 240 million doses which are due to expire at the end of February.

“Many of the same rich country governments that this guidance applies to are also those continuing to block proposals to enable and encourage the widescale generic production of COVID-19 vaccines in developing countries – measures that would scale up vaccine access, drive down prices and diminish the need for donations in the first place.

“If generic production of vaccines were allowed, each $6.72 of aid could purchase five vaccine doses, instead of just one.”

 

Notes:

EU set to bin 25 million more vaccine doses than it has donated to Africa this year

Europe has betrayed Africa by blocking proposals which would allow manufacturers on the continent to make their own COVID-19 vaccines while hoarding millions of doses which are set to expire at the end of the month, warns the People’s Vaccine Alliance ahead of tomorrow’s meeting of African and European leaders at the AU-EU Summit.

According to new analysis from the Alliance, the EU will have to throw away 55 million doses of COVID vaccines by the end of February, many more than the 30 million doses they have donated to Africa so far in 2022.

Despite the rhetoric of a special relationship with Africa, the EU – which is now the world’s biggest exporter of vaccines – has prioritised selling vaccines made on EU soil for eye-watering prices to rich nations and just eight per cent of its vaccine exports have gone to the African continent. The figures for Germany are even worse; just one per cent of vaccine exports from BioNTech, the German pharmaceutical company behind the Pfizer vaccine, have gone to Africa.

At the same time, EU member states, led by Germany, have been a major blocker of proposals tabled by South Africa and India and supported by the African Union and over 100 countries for an intellectual property waiver which would allow the generic production of COVID vaccines, tests and treatments. Leaked drafts of the summit declaration show a divide between the EU and the AU, with the AU insisting language on the waiver is included. Last summer, French President Emmanuel Macron – who is hosting the AU-EU summit – announced his support for the waiver but has done little since to challenge the EU’s stance on the issue.

It is estimated that a quarter of a million people have died as a result of COVID-19 in Africa since the beginning of the year, almost 7,000 people a day. Due to very low vaccine supplies, just 11 per cent of people on the continent have received their first two COVID vaccines to date. The number of people who have had a booster jab in the EU outnumber those in Africa who have had two doses by more than a third. 

The People’s Vaccine Alliance, a group of nearly 100 organisations including African Alliance, Christian Aid, Oxfam, Public Services International and UNAIDS, says the EU should be held to account for the lack of vaccines in Africa, because it has stood so firmly in the way of the continent being able to produce its own doses.

Joab Okanda, Pan Africa Senior Advocacy Advisor for Christian Aid, said: “European Commission President, Ursula Von der Leyen, said at the beginning of the pandemic that the vaccine should be a global public good. Yet instead, she has ensured it is a private profit opportunity, raking in billions for Big Pharma and the EU, while almost 9 out of 10 people in Africa aren’t fully vaccinated, two years into this deadly pandemic. This is shameful.”

The EU has made much of plans to support the set-up of vaccine factories in Africa under the monopoly control of European pharmaceutical corporations – but this still wouldn’t give countries autonomy on vaccine supplies produced. BioNTech recently announced plans to produce 50 million vaccines in Africa once fully operational, however this is less than their factory in Germany produces each month.

Anna Marriott, Health Policy Manager at Oxfam, said: “Europe must stop blocking African producers from making their own doses of COVID vaccines. If there truly is a common agenda between the Unions, then the EU would stop putting the interests of pharmaceutical companies, who have reaped billions from the pandemic, ahead of African lives.

“These vaccines were publicly funded, and the recipes should be shared with the world to allow all qualified producers to make these vital shots.”

The EU have contributed €3 billion in funding to COVAX, the initiative designed to help developing countries to access vaccine doses, but the scheme has now run out of funds after failing to reach its target of vaccinating 20 per cent of people in poorer countries by the end of 2021. Meanwhile, Germany alone has received back €3.2 billion in tax revenue from BioNTech.

Sani Baba Mohammed, Public Services International Regional Secretary for Africa and Arab countries, said:  “The EU claims they are promoting a ‘prosperous partnership of equals’ with the African Union – yet they are throwing more vaccine doses in the trash than they are donating to us, while continuing to block a waiver on vaccine patents which would enable us to produce our own vaccines. What’s equal about that?

“This vaccine apartheid – perpetuated by the EU – has a brutal human cost. Our livelihoods continue to be destroyed, our economies shattered, our health workers pushed beyond the brink.

“It is encouraging that the African Union is standing up to the EU and asking for a reference to the TRIPS waiver to be included in the Summit’s outcome document. We need the TRIPS waiver now and the EU must stop standing in the way.”

 

Notes to editors:

  • In a draft declaration, the EU has said “we support a common agenda for manufacturing vaccines, medicines and health products in Africa, including investment in production capacities, the use of intellectual property, voluntary technology transfers as well as strengthening of the regulatory framework to enable equitable access to vaccines, diagnostics and therapeutics.”
  • The Africa Group is a co-sponsor of the TRIPS waiver proposal, and the African Union passed a motion at the 34th summit of the Africa Union calling for a temporary WTO waiver of intellectual property obligations to enable the manufacture and distribution of COVID-19 vaccines in Africa. See here.
  • Data on number of doses donated to Africa analysed between 1st January 2022– 8th February 2022 from Airfinity. Data that the EU has 55 million doses due to expire at the end of February 2022 also from Airfinity.
  • Vaccination rate data from Our World In Data – 151 million people are fully vaccinated in Africa and 204 million people in the EU have received boosters.
  • Just 8 per cent of EU’s vaccine exports so far this year have been to Africa. The figure for exports from Germany is 1.4 per cent and from Netherlands and Belgium the figure is 43 per cent. Data from Airfinity.
  • Estimates on number of COVID deaths in Africa are from the Economist.

Copyright © 2024 Oxfam Aotearoa.

Oxfam is a worldwide development organisation that mobilises the power of people against injustice. Oxfam Aotearoa is a registered charity with the New Zealand Charities Register (registration CC24641). Donations are tax refundable.

Site by